Filing Details

Accession Number:
0001209191-13-055724
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-06 16:22:04
Reporting Period:
2013-12-04
Filing Date:
2013-12-06
Accepted Time:
2013-12-06 16:22:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1168197 Liposcience Inc LPDX In Vitro & In Vivo Diagnostic Substances (2835) 561879288
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1530868 Duffy E. Mcdonald C/O Liposcience, Inc.
2500 Sumner Boulevard
Raleigh NC 27616
Vice President, Hr No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-12-04 12,731 $2.50 16,496 No 4 M Direct
Common Stock Disposition 2013-12-04 12,731 $4.07 3,765 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2013-12-04 12,731 $0.00 12,731 $2.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2013-12-12 No 4 M Direct
Footnotes
  1. Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $3.98 to $4.22 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  2. The option vested over a period of four years, with 25% of the shares underlying the option vested on November 24, 2004, with the remainder vesting in 36 equal monthly installments thereafter.